Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 3
1969 2
1970 7
1971 3
1972 5
1973 2
1974 1
1975 1
1976 4
1977 2
1978 2
1980 2
1981 1
1982 1
1983 4
1984 2
1985 2
1986 5
1987 7
1988 6
1989 4
1990 11
1991 8
1992 7
1993 15
1994 12
1995 4
1996 11
1997 7
1998 3
1999 10
2000 7
2001 13
2002 13
2003 14
2004 8
2005 12
2006 12
2007 10
2008 19
2009 15
2010 10
2011 10
2012 9
2013 17
2014 12
2015 23
2016 14
2017 15
2018 15
2019 12
2020 16
2021 11
2022 14
2023 10
2024 10
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

437 results

Results by year

Filters applied: . Clear all
Page 1
Telmisartan, ramipril, or both in patients at high risk for vascular events.
ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. ONTARGET Investigators, et al. N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Free article. Clinical Trial.
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators; Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, et al. Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Lancet. 2008. PMID: 18757085 Clinical Trial.
Dominant CST3 variants cause adult onset leukodystrophy without amyloid angiopathy.
Bergner CG, Breur M, Soto-Bernardini MC, Schäfer L, Lier J, Le Duc D, Bundalian L, Schubert S, Brenner D, Kreuz FR, Schulte B, Waisfisz Q, Bugiani M, Köhler W, Sticht H, Abou Jamra R, van der Knaap MS. Bergner CG, et al. Among authors: lier j. Brain. 2024 Oct 3;147(10):3562-3572. doi: 10.1093/brain/awae085. Brain. 2024. PMID: 38489591
Principles, Advances, and Perspectives of Anaerobic Digestion of Lipids.
Holohan BC, Duarte MS, Szabo-Corbacho MA, Cavaleiro AJ, Salvador AF, Pereira MA, Ziels RM, Frijters CTMJ, Pacheco-Ruiz S, Carballa M, Sousa DZ, Stams AJM, O'Flaherty V, van Lier JB, Alves MM. Holohan BC, et al. Among authors: van lier jb. Environ Sci Technol. 2022 Apr 19;56(8):4749-4775. doi: 10.1021/acs.est.1c08722. Epub 2022 Mar 31. Environ Sci Technol. 2022. PMID: 35357187 Review.
First-in-human study evaluating safety, pharmacokinetics, and pharmacodynamics of lorundrostat, a novel and highly selective aldosterone synthase inhibitor.
Shimizu H, Tortorici MA, Ohta Y, Ogawa K, Rahman SMA, Fujii A, Hiraga Y, Kawai M, Sugimoto-Kawabata K, van Iersel MT, van Lier JJ, Djedjos S, Slingsby BT, Rodman DM. Shimizu H, et al. Among authors: van lier jj. Clin Transl Sci. 2024 Aug;17(8):e70000. doi: 10.1111/cts.70000. Clin Transl Sci. 2024. PMID: 39152532 Free PMC article. Clinical Trial.
437 results